[Amizon in the treatment of nervous system involvement in herpes zoster].
The authors submit results of treatment of patients having suffered from postherpetic pain syndrome (herpetic ganglionitis of the cervical, thoracic, lumbosacral localization, postherpetic intercostal neuralgia, ganglionitis of the trigeminal nerve). In viral diseases, amizone has marked analgetic, antiinflammatory, and immunomodulating effects. The drug is well tolerated by patients, is not associated with side effects under prescribed doses (0.25-0.75 as one dose on a three- or four-times daily schedule during the course of treatment lasting three or four weeks). The drug preparation in question is less effective in the treatment of chronic recurring post-therapeutic intercostal neuralgias, radiculalgia.
Rudenko
A E
AE
Trinus
F P
FP
Korzhenevskiĭ
L V
LV
Bukhtiarova
T A
TA
Koval'
A Z
AZ
Malyĭ
V D
VD
Novikova
O V
OV
Tkachenko
E V
EV
D000328:Adult; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006562:Herpes Zoster / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy; D010148:Intractable Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011843:Radiculopathy / Q000188:drug therapy; D013607:Tablets
D018712:Analgesics, Non-Narcotic; D013607:Tablets